Eric Paul Lefkofsky, an American entrepreneur, is a co-founder of the Tempus. Other companies that he co-founded include Groupon, Inner workings, Logistics, Mediaocean, Lightbank, and Uptake. Eric Lefkofsky also co-chairs Lefkofsky Family Foundation with his wife. Eric Paul Lefkofsky was born in the year n1969 in Southfield Michigan. He was born to Jewish parents, Bill and Sandy. Bill is a structural Engineer during Sandy a school teacher. He schooled at the Southfield Lathrup high school after which he pursued his degree at the University of Michigan. Eric Paul Lefkofsky furthered his studies in the same university school of law and attained his Juris doctor in the year 1993.Eric Paul Lefkofsky ventured into the business of selling carpets in his school life. After his law studies, Eric Paul Lefkofsky organized with one of his friends on acquiring capital from their relative to buy an apparel company. They bought the Brandon Company, which is situated at Michigan and learn more about Eric.
Tempus is a company dedicated to research on the genome and how the genomic information is used in the modern clinical field. Tempus main aim is to ensure that every new patient receives improved service based on the research done from the previous patient. The visiting patients provide the very physician time with new information and data to research on. Eric Lefkofsky is the current CEO of Tempus. Tempus provides the physicians with the ability to access various sequencing capabilities. Tempus partners with other doctors and hospitals. This partnership is meant to improve genome sequencing with a sharp machine learning platform. It also draws data from biological models and single cell genomes and Eric’s lacrosse camp.
For the past decades, cancer studies have led to advancements in the identification of the alterations of genes that propagates the growth of tumors. These improvements carefully give the progression of the cancerous tumor growth. Cancer is spread to the body cells by the abnormalities in the genes found in a person’s cell. Tempus tests on the genomic have helped identify unique alterations. Proper therapies and clinical interventions can now be derived and applied by the physicians in the right treatment of the disease and more information click here.
More Visit: https://www.facebook.com/eplefkofsky/